Wegovy, other weight-loss drugs scrutinized over reports of

“I knew it was the drug,” said Heidlebaugh, who said she had not previously suffered from depression. Heidlebaugh is one of four U.S. patients who told Reuters about experiencing suicidal thoughts while taking Novo Nordisk’s popular Ozempic drug, approved to treat type 2 diabetes, or Wegovy, another Novo top-seller approved for weight loss. A fifth patient said he experienced depression and suicidal thoughts after taking Mounjaro, a similar diabetes medicine from Eli Lilly, which is also used for weight loss.

Related Keywords

Canada , Indiana , United States , Ohio , Oregon , North Carolina , United Kingdom , New York , Novo Saxenda , Brian Thevenot , Maggie Fick , Sarah Sobol , Jayson Chesnutt , Oderick Turner , Robin Respaut , Thomasj Moore , Lisa Wood , John Amos , Eli Lilly , Sanofi Acomplia , Michele Gershberg , Ludwig Burger , European Medicines Agency , Novo Nordisk , Oregon Health Science University , Drug Administration , Reuters , Facebook , Currax Pharmaceuticals , Johns Hopkins Bloomberg School Of Public Health , European Union , Johns Hopkins Bloomberg School , Public Health , Oregon Health , Chad Terhune , Suicidal Thoughts , Weight Loss , Food And Drug Administration , Psychiatric Drugs ,